Detailed TOC of Global Fentanyl Market Research Report 2032
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fentanyl Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fentanyl Injections
1.2.3 Fentanyl TTS
1.3 Market by Application
1.3.1 Global Fentanyl Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fentanyl Market Perspective (2019-2030)
2.2 Fentanyl Growth Trends by Region
2.2.1 Global Fentanyl Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fentanyl Historic Market Size by Region (2019-2032)
2.2.3 Fentanyl Forecasted Market Size by Region (2025-2030)
2.3 Fentanyl Market Dynamics
2.3.1 Fentanyl Industry Trends
2.3.2 Fentanyl Market Drivers
2.3.3 Fentanyl Market Challenges
2.3.4 Fentanyl Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fentanyl Players by Revenue
3.1.1 Global Top Fentanyl Players by Revenue (2019-2032)
3.1.2 Global Fentanyl Revenue Market Share by Players (2019-2032)
3.2 Global Fentanyl Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fentanyl Revenue
3.4 Global Fentanyl Market Concentration Ratio
3.4.1 Global Fentanyl Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fentanyl Revenue in 2023
3.5 Fentanyl Key Players Head office and Area Served
3.6 Key Players Fentanyl Product Solution and Service
3.7 Date of Enter into Fentanyl Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fentanyl Breakdown Data by Type
4.1 Global Fentanyl Historic Market Size by Type (2019-2032)
4.2 Global Fentanyl Forecasted Market Size by Type (2025-2030)
5 Fentanyl Breakdown Data by Application
5.1 Global Fentanyl Historic Market Size by Application (2019-2032)
5.2 Global Fentanyl Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fentanyl Market Size (2019-2030)
6.2 North America Fentanyl Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fentanyl Market Size by Country (2019-2032)
6.4 North America Fentanyl Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fentanyl Market Size (2019-2030)
7.2 Europe Fentanyl Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fentanyl Market Size by Country (2019-2032)
7.4 Europe Fentanyl Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fentanyl Market Size (2019-2030)
8.2 Asia-Pacific Fentanyl Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fentanyl Market Size by Region (2019-2032)
8.4 Asia-Pacific Fentanyl Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fentanyl Market Size (2019-2030)
9.2 Latin America Fentanyl Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fentanyl Market Size by Country (2019-2032)
9.4 Latin America Fentanyl Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fentanyl Market Size (2019-2030)
10.2 Middle East & Africa Fentanyl Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fentanyl Market Size by Country (2019-2032)
10.4 Middle East & Africa Fentanyl Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Fentanyl Introduction
11.1.4 Johnson & Johnson Revenue in Fentanyl Business (2019-2032)
11.1.5 Johnson & Johnson Recent Development
11.2 GREENLEAF
11.2.1 GREENLEAF Company Detail
11.2.2 GREENLEAF Business Overview
11.2.3 GREENLEAF Fentanyl Introduction
11.2.4 GREENLEAF Revenue in Fentanyl Business (2019-2032)
11.2.5 GREENLEAF Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Detail
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Fentanyl Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Fentanyl Business (2019-2032)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Hisamitsu
11.4.1 Hisamitsu Company Detail
11.4.2 Hisamitsu Business Overview
11.4.3 Hisamitsu Fentanyl Introduction
11.4.4 Hisamitsu Revenue in Fentanyl Business (2019-2032)
11.4.5 Hisamitsu Recent Development
11.5 MEDRx Co Ltd
11.5.1 MEDRx Co Ltd Company Detail
11.5.2 MEDRx Co Ltd Business Overview
11.5.3 MEDRx Co Ltd Fentanyl Introduction
11.5.4 MEDRx Co Ltd Revenue in Fentanyl Business (2019-2032)
11.5.5 MEDRx Co Ltd Recent Development
11.6 Insys Therapeutics
11.6.1 Insys Therapeutics Company Detail
11.6.2 Insys Therapeutics Business Overview
11.6.3 Insys Therapeutics Fentanyl Introduction
11.6.4 Insys Therapeutics Revenue in Fentanyl Business (2019-2032)
11.6.5 Insys Therapeutics Recent Development
11.7 Alvogen
11.7.1 Alvogen Company Detail
11.7.2 Alvogen Business Overview
11.7.3 Alvogen Fentanyl Introduction
11.7.4 Alvogen Revenue in Fentanyl Business (2019-2032)
11.7.5 Alvogen Recent Development
11.8 Apotex Inc
11.8.1 Apotex Inc Company Detail
11.8.2 Apotex Inc Business Overview
11.8.3 Apotex Inc Fentanyl Introduction
11.8.4 Apotex Inc Revenue in Fentanyl Business (2019-2032)
11.8.5 Apotex Inc Recent Development
11.9 Kyowa Kirin Co., Ltd
11.9.1 Kyowa Kirin Co., Ltd Company Detail
11.9.2 Kyowa Kirin Co., Ltd Business Overview
11.9.3 Kyowa Kirin Co., Ltd Fentanyl Introduction
11.9.4 Kyowa Kirin Co., Ltd Revenue in Fentanyl Business (2019-2032)
11.9.5 Kyowa Kirin Co., Ltd Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Fentanyl Introduction
11.10.4 Mylan Revenue in Fentanyl Business (2019-2032)
11.10.5 Mylan Recent Development
11.11 Sinopharm Group
11.11.1 Sinopharm Group Company Detail
11.11.2 Sinopharm Group Business Overview
11.11.3 Sinopharm Group Fentanyl Introduction
11.11.4 Sinopharm Group Revenue in Fentanyl Business (2019-2032)
11.11.5 Sinopharm Group Recent Development
11.12 Yichang Renfu Pharmaceutical
11.12.1 Yichang Renfu Pharmaceutical Company Detail
11.12.2 Yichang Renfu Pharmaceutical Business Overview
11.12.3 Yichang Renfu Pharmaceutical Fentanyl Introduction
11.12.4 Yichang Renfu Pharmaceutical Revenue in Fentanyl Business (2019-2032)
11.12.5 Yichang Renfu Pharmaceutical Recent Development
11.13 Jiangsu Enhua Pharmaceutical
11.13.1 Jiangsu Enhua Pharmaceutical Company Detail
11.13.2 Jiangsu Enhua Pharmaceutical Business Overview
11.13.3 Jiangsu Enhua Pharmaceutical Fentanyl Introduction
11.13.4 Jiangsu Enhua Pharmaceutical Revenue in Fentanyl Business (2019-2032)
11.13.5 Jiangsu Enhua Pharmaceutical Recent Development
11.14 Changzhou Siyao Pharmaceutical
11.14.1 Changzhou Siyao Pharmaceutical Company Detail
11.14.2 Changzhou Siyao Pharmaceutical Business Overview
11.14.3 Changzhou Siyao Pharmaceutical Fentanyl Introduction
11.14.4 Changzhou Siyao Pharmaceutical Revenue in Fentanyl Business (2019-2032)
11.14.5 Changzhou Siyao Pharmaceutical Recent Development
11.15 Henan Lingrui Pharmaceutical
11.15.1 Henan Lingrui Pharmaceutical Company Detail
11.15.2 Henan Lingrui Pharmaceutical Business Overview
11.15.3 Henan Lingrui Pharmaceutical Fentanyl Introduction
11.15.4 Henan Lingrui Pharmaceutical Revenue in Fentanyl Business (2019-2032)
11.15.5 Henan Lingrui Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
